{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:16:17Z","timestamp":1782818177413,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national nature science foundation of China","doi-asserted-by":"crossref","award":["NO.81601048"],"award-info":[{"award-number":["NO.81601048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"national nature science foundation of China","doi-asserted-by":"crossref","award":["NO.81571173"],"award-info":[{"award-number":["NO.81571173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10753-017-0589-2","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T02:00:39Z","timestamp":1495072839000},"page":"1460-1473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis"],"prefix":"10.1007","volume":"40","author":[{"given":"Weifan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"589_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(85)80045-X","volume":"8","author":"P Christadoss","year":"1985","unstructured":"Christadoss, P., J. Lindstrom, S. Munro, and N. Talal. 1985. Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: Correlated with cellular, humoral and clinical responses. Journal of Neuroimmunology 8: 29\u201344.","journal-title":"Journal of Neuroimmunology"},{"key":"589_CR2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman, D.B. 1994. Myasthenia gravis. The New England Journal of Medicine 330: 1797\u20131810.","journal-title":"The New England Journal of Medicine"},{"key":"589_CR3","first-page":"82","volume":"67","author":"A Rodgaard","year":"1987","unstructured":"Rodgaard, A., F.C. Nielsen, R. Djurup, F. Somnier, and S. Gammeltoft. 1987. Acetylcholine receptor antibody in myasthenia gravis: Predominance of IgG subclasses 1 and 3. J Clin. Exp Immunol 67: 82\u201388.","journal-title":"J Clin. Exp Immunol"},{"key":"589_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","volume":"94","author":"P Christadoss","year":"2000","unstructured":"Christadoss, P., M. Poussin, and C. Deng. 2000. Animal models of myasthenia gravis. Clinical Immunology 94: 75\u201387.","journal-title":"Clinical Immunology"},{"key":"589_CR5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mus.24438","volume":"51","author":"T Imai","year":"2015","unstructured":"Imai, T., S. Suzuki, E. Tsuda, Y. Nagane, H. Murai, M. Masuda, S. Konno, Y. Suzuki, S. Nakane, K. Fujihara, N. Suzuki, and K. Utsugisawa. 2015. Oral corticosteroid therapy and present disease status in myasthenia gravis. Muscle & Nerve 51: 692\u2013696.","journal-title":"Muscle & Nerve"},{"key":"589_CR6","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.4049\/jimmunol.1401392","volume":"193","author":"J Luo","year":"2014","unstructured":"Luo, J., and J. Lindstrom. 2014. Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis. Journal of Immunology 193: 5044\u20135055.","journal-title":"Journal of Immunology"},{"key":"589_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245\u2013252.","journal-title":"Nature"},{"key":"589_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fimmu.2015.00535","volume":"6","author":"F Osorio","year":"2015","unstructured":"Osorio, F., C. Fuentes, M.N. L\u00f3pez, F. Salazar-Onfray, and F.E. Gonz\u00e1lez. 2015. Role of dendritic cells in the induction of lymphocyte tolerance. Frontiers in Immunology 6: 535.","journal-title":"Frontiers in Immunology"},{"key":"589_CR9","doi-asserted-by":"crossref","first-page":"972865","DOI":"10.1155\/2013\/972865","volume":"2013","author":"CY Chung","year":"2013","unstructured":"Chung, C.Y., D. Ysebaert, Z.N. Berneman, and N. Cools. 2013. Dendritic cells: Cellular mediators for immunological tolerance. Clinical & Developmental Immunology 2013: 972865.","journal-title":"Clinical & Developmental Immunology"},{"key":"589_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","volume":"10","author":"RM O\u2019Connell","year":"2010","unstructured":"O\u2019Connell, R.M., D.S. Rao, A.A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nature Reviews. Immunology 10: 111\u2013122.","journal-title":"Nature Reviews. Immunology"},{"key":"589_CR11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2012.09.024","volume":"48","author":"T Fukaya","year":"2012","unstructured":"Fukaya, T., and Y. Tomari. 2012. MicroRNAs mediate gene silencing via multiple different pathways in Drosophila. Molecular Cell 48: 825\u2013836.","journal-title":"Molecular Cell"},{"key":"589_CR12","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1007\/s12032-012-0175-2","volume":"29","author":"J Du","year":"2012","unstructured":"Du, J., J. Wang, G. Tan, Z. Cai, L. Zhang, B. Tang, and Z. Wang. 2012. Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activation. Medical Oncology 29: 2814\u20132823.","journal-title":"Medical Oncology"},{"key":"589_CR13","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood-2012-12-475087","volume":"122","author":"JJ Karrich","year":"2013","unstructured":"Karrich, J.J., L.C. Jachimowski, M. Libouban, A. Iyer, K. Brandwijk, E.W. Taanman-Kueter, M. Nagasawa, E.C. de Jong, C.H. Uittenbogaart, and B. Blom. 2013. MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood 122: 3001\u20133009.","journal-title":"Blood"},{"key":"589_CR14","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","volume":"290","author":"H Park","year":"2015","unstructured":"Park, H., X. Huang, C. Lu, M.S. Cairo, and X. Zhou. 2015. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. The Journal of Biological Chemistry 290: 2831\u20132841.","journal-title":"The Journal of Biological Chemistry"},{"key":"589_CR15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.febslet.2011.01.010","volume":"585","author":"T Chen","year":"2011","unstructured":"Chen, T., Z. Li, T. Jing, W. Zhu, J. Ge, X. Zheng, X. Pan, H. Yan, and J. Zhu. 2011. MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Letters 585: 567\u2013573.","journal-title":"FEBS Letters"},{"key":"589_CR16","first-page":"2665","volume":"20","author":"B Bodey","year":"2000","unstructured":"Bodey, B., Jr B. Bodey, S.E. Siegel, and H.E. Kaiser. 2000. Failure of cancer vaccines: The significant limitations of this approach to immunotherapy. Anticancer Research 20: 2665\u20132676.","journal-title":"Anticancer Research"},{"key":"589_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bcmd.2005.05.003","volume":"35","author":"E Segura","year":"2005","unstructured":"Segura, E., S. Amigorena, and C. Th\u00e9ry. 2005. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells, Molecules & Diseases 35: 89.","journal-title":"Blood Cells, Molecules & Diseases"},{"key":"589_CR18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10753-012-9539-1","volume":"36","author":"W Yin","year":"2013","unstructured":"Yin, W., S. Ouyang, Y. Li, B. Xiao, and H. Yang. 2013. Immature dendritic cell-derived exosomes: A promise subcellular vaccine for autoimmunity. Inflammation 36: 232\u2013240.","journal-title":"Inflammation"},{"key":"589_CR19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1600-6143.2006.01344.x","volume":"6","author":"H P\u00eache","year":"2006","unstructured":"P\u00eache, H., K. Renaudin, G. Beriou, E. Merieau, S. Amigorena, and M.C. Cuturi. 2006. Induction of tolerance by exosome and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am Transplantat 6: 1541\u20131550.","journal-title":"Am Transplantat"},{"key":"589_CR20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jss.2010.05.021","volume":"171","author":"X Yang","year":"2011","unstructured":"Yang, X., S. Meng, H. Jiang, C. Zhu, and W. Wu. 2011. Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats. The Journal of Surgical Research 171: 826\u2013832.","journal-title":"The Journal of Surgical Research"},{"key":"589_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymthe.2005.09.015","volume":"13","author":"SH Kim","year":"2006","unstructured":"Kim, S.H., N. Bianco, R. Menon, E.R. Lechman, W.J. Shufesky, A.E. Morelli, and P.D. Robbins. 2006. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Molecular Therapy 13: 289\u2013300.","journal-title":"Molecular Therapy"},{"key":"589_CR22","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.4049\/jimmunol.179.4.2242","volume":"179","author":"SH Kim","year":"2007","unstructured":"Kim, S.H., N.R. Bianco, W.J. Shufesky, A.E. Morelli, and P.D. Robbins. 2007. Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. Journal of Immunology 179: 2242\u20132249.","journal-title":"Journal of Immunology"},{"key":"589_CR23","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.4049\/jimmunol.174.10.6440","volume":"174","author":"SH Kim","year":"2005","unstructured":"Kim, S.H., E.R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S.C. Watkins, A. Gambotto, and P.D. Robbins. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. Journal of Immunology 174: 6440\u20136448.","journal-title":"Journal of Immunology"},{"key":"589_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2015.04.009","volume":"285","author":"N Bu","year":"2015","unstructured":"Bu, N., H.Q. Wu, G.L. Zhang, S.Q. Zhan, R. Zhang, Q.Y. Fan, Y.L. Li, Y.F. Zhai, and H.W. Ren. 2015. Immature dendritic cell exosomes suppress experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 285: 71\u201375.","journal-title":"Journal of Neuroimmunology"},{"key":"589_CR25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-016-0475-0","volume":"13","author":"XL Li","year":"2016","unstructured":"Li, X.L., H. Li, M. Zhang, H. Xu, L.T. Yue, X.X. Zhang, S. Wang, C.C. Wang, Y.B. Li, Y.C. Dou, and R.S. Duan. 2016. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO\/Treg and partly dependent on FasL\/Fas pathway. Journal of Neuroinflammation 13: 8.","journal-title":"Journal of Neuroinflammation"},{"key":"589_CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.164.1.161","volume":"164","author":"WP Min","year":"2000","unstructured":"Min, W.P., R. Gorczynski, X.Y. Huang, M. Kushida, P. Kim, M. Obataki, J. Lei, R.M. Suri, and M.S. Cattral. 2000. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. Journal of Immunology 164: 161\u2013167.","journal-title":"Journal of Immunology"},{"key":"589_CR27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.molimm.2011.04.021","volume":"48","author":"K Doffek","year":"2011","unstructured":"Doffek, K., X. Chen, S.L. Sugg, and J. Shilyansky. 2011. Phosphatidylserine inhibits NF-\u03baB and p38 MAPK activation in human monocyte derived dendritic cells. Molecular Immunology 48: 1771\u20131777.","journal-title":"Molecular Immunology"},{"key":"589_CR28","doi-asserted-by":"crossref","unstructured":"Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol 169:3555\u20133564.","DOI":"10.4049\/jimmunol.169.7.3555"},{"key":"589_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-61779-083-6_9","volume":"732","author":"PA Manavella","year":"2011","unstructured":"Manavella, P.A., and I. Rubio-Somoza. 2011. Engineering elements for gene silencing: The artificial microRNAs technology. Methods in Molecular Biology 732: 121\u2013123.","journal-title":"Methods in Molecular Biology"},{"key":"589_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2013.10.014","volume":"266","author":"AD Pusic","year":"2014","unstructured":"Pusic, A.D., K.M. Pusic, B.L. Clayton, and R.P. Kraig. 2014. IFN\u03b3-stimulated dendritic cell exosomes as a potential therapeutic for remyelination. Journal of Neuroimmunology 266: 12\u201323.","journal-title":"Journal of Neuroimmunology"},{"key":"589_CR31","doi-asserted-by":"crossref","first-page":"e44045","DOI":"10.1371\/journal.pone.0044045","volume":"7","author":"X Li","year":"2012","unstructured":"Li, X., J.J. Li, J.Y. Yang, D.S. Wan, W. Zhao, W.J. Song, W.M. Li, J.F. Wang, W. Han, Z.C. Zhang, Y. Yu, D.Y. Cao, and K.F. Dou. 2012. Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model. PloS One 7: e44045.","journal-title":"PloS One"},{"issue":"11","key":"589_CR32","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2215\/CJN.06620714","volume":"10","author":"BM Hall","year":"2015","unstructured":"Hall, B.M. 2015. T cell: Soldiers and spies\u2014The surveillance and control of effector T cells by regulatory T cell. Clinical Journal of the American Society of Nephrology 10 (11): 2050\u20132064.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"2","key":"589_CR33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","volume":"72","author":"RM Talaat","year":"2015","unstructured":"Talaat, R.M., S.F. Mohamed, I.H. Bassyouni, and A.A. Raouf. 2015. Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 72 (2): 146\u2013153.","journal-title":"Cytokine"},{"issue":"5","key":"589_CR34","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/mmr.2012.1055","volume":"6","author":"J Xiao","year":"2012","unstructured":"Xiao, J., F. Zhu, X. Liu, and J. Xiong. 2012. Th1\/Th2\/Th17\/Treg expression in cultured PBMCs with antiphospholipid antibodies. Molecular Medicine Reports 6 (5): 1035\u20131039.","journal-title":"Molecular Medicine Reports"},{"key":"589_CR35","first-page":"591237","volume":"2015","author":"PB Alexandre","year":"2015","unstructured":"Alexandre, P.B., D.B. Rodrigues, and V. Rodrigues. 2015. Expression pattern of transcription factors and intracellular cytokines reveals that clinically cured tuberculosis is accompanied by an increase in Mycobacterium-specific Th1, Th2, and Th17 cells. BioMed Research International 2015: 591237.","journal-title":"BioMed Research International"},{"issue":"4","key":"589_CR36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt, J.M., F. Andr\u00e9, S. Amigorena, J.C. Soria, A. Eggermont, G. Kroemer, and L. Zitvogel. 2016. Dendritic cell-derived exosomes for cancer therapy. The Journal of Clinical Investigation 126 (4): 1224\u20131232.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"589_CR37","first-page":"889","volume":"10","author":"A Tan","year":"2010","unstructured":"Tan, A., H. De La Pe\u00f1a, and A.M. Seifalian. 2010. The application of exosomes as a nanoscale cancer vaccine. International Journal of Nanomedicine 10 (5): 889\u2013900.","journal-title":"International Journal of Nanomedicine"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-017-0589-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-017-0589-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-017-0589-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:03:35Z","timestamp":1569341015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-017-0589-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1007\/s10753-017-0589-2","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}